$6.16
Singular Genomics Systems is a medical instruments & supplies business based in the US. Singular Genomics Systems shares (OMIC) are listed on the NASDAQ and all prices are listed in US Dollars. Singular Genomics Systems employs 255 staff and has a trailing 12-month revenue of around $2.7 million.
Our top picks for where to buy Singular Genomics Systems stock
How to buy Singular Genomics Systems stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – OMIC. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Singular Genomics Systems stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Singular Genomics Systems stock price (NASDAQ: OMIC)
Use our graph to track the performance of OMIC stocks over time.Singular Genomics Systems shares at a glance
Latest market close | $6.28 |
---|---|
52-week range | $5.77 - $19.80 |
50-day moving average | $7.82 |
200-day moving average | $11.98 |
Wall St. target price | $6.50 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-37.28 |
Is it a good time to buy Singular Genomics Systems stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Singular Genomics Systems price performance over time
Historical closes compared with the close of $6.2759 from 2024-09-03
1 week (2024-08-29) | -11.48% |
---|---|
1 month (2024-08-05) | -13.44% |
3 months (2024-06-05) | 1,647.67% |
6 months (2024-03-05) | 1,022.50% |
1 year (2023-09-05) | 1,246.76% |
---|---|
2 years (2022-09-02) | 150.04% |
3 years (2021-09-03) | 17.83 |
5 years (2019-09-01) | N/A |
Singular Genomics Systems financials
Revenue TTM | $2.7 million |
---|---|
Gross profit TTM | $-24,000 |
Return on assets TTM | -24.27% |
Return on equity TTM | -51.61% |
Profit margin | 0% |
Book value | $55.27 |
Market Capitalization | $17.7 million |
TTM: trailing 12 months
Singular Genomics Systems share dividends
We're not expecting Singular Genomics Systems to pay a dividend over the next 12 months.
Have Singular Genomics Systems's shares ever split?
Singular Genomics Systems's shares were split on a 1:30 basis on 25 June 2024. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Singular Genomics Systems shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Singular Genomics Systems shares which in turn could have impacted Singular Genomics Systems's share price.
Singular Genomics Systems share price volatility
Over the last 12 months, Singular Genomics Systems's shares have ranged in value from as little as $5.77 up to $19.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Singular Genomics Systems's is 1.349. This would suggest that Singular Genomics Systems's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put Singular Genomics Systems's beta into context you can compare it against those of similar companies.
- Illumina (ILMN.US): 1.149
- Crispr Therapeutics (CRSP.US): 1.695
- Bionano Genomics (BNGO.US): 2.333
Singular Genomics Systems overview
Singular Genomics Systems, Inc. , a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California. .
Frequently asked questions
What percentage of Singular Genomics Systems is owned by insiders or institutions?Currently 13.901% of Singular Genomics Systems shares are held by insiders and 41.232% by institutions. How many people work for Singular Genomics Systems?
Latest data suggests 255 work at Singular Genomics Systems. When does the fiscal year end for Singular Genomics Systems?
Singular Genomics Systems's fiscal year ends in December. Where is Singular Genomics Systems based?
Singular Genomics Systems's address is: 3010 Science Park Road, San Diego, CA, United States, 92121 What is Singular Genomics Systems's ISIN number?
Singular Genomics Systems's international securities identification number is: US82933R1005
More guides on Finder
-
Options profit calculator
Use this calculator to quickly see potential outcomes of your options trades.
-
Best options trading platforms of 2024
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
-
What is a covered call?
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
-
GSD Capital review 2024
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 E*TRADE competitors worth your time
Looking for a discount broker like E*TRADE that offers something different? Here are some of the top alternatives to consider.
-
Charles Schwab vs. Fidelity
Charles Schwab and Fidelity are two powerhouse trading platforms for beginner and advanced investors.
-
Interactive Brokers review 2024: Tailored trading and investing
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
-
Top 15 tech stocks to invest in for 2024
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Ask a question